These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22867847)

  • 21. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol.
    Hardwick M; Fertikh D; Culty M; Li H; Vidic B; Papadopoulos V
    Cancer Res; 1999 Feb; 59(4):831-42. PubMed ID: 10029072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?
    Ito Y; Iwase T; Hatake K
    Breast Cancer; 2012 Jul; 19(3):206-11. PubMed ID: 21526426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
    Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
    Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK; Sanders BG; Kline K
    Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel design of targeted endocrine and cytokine therapy for breast cancer.
    Zhang G; Li W; Holle L; Chen N; Chen WY
    Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models.
    Shen G; Huang H; Zhang A; Zhao T; Hu S; Cheng L; Liu J; Xiao W; Ling B; Wu Q; Song L; Wei W
    Cancer Immunol Immunother; 2011 Mar; 60(3):339-48. PubMed ID: 21086124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth effect of neutrophil elastase on breast cancer: favorable action of sivelestat and application to anti-HER2 therapy.
    Nawa M; Osada S; Morimitsu K; Nonaka K; Futamura M; Kawaguchi Y; Yoshida K
    Anticancer Res; 2012 Jan; 32(1):13-9. PubMed ID: 22213283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
    Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
    Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
    Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
    J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of breast cancer treatments on plasma nutrient levels: implications for epidemiological studies.
    Potischman N; Byers T; Houghton L; Root M; Nemoto T; Campbell TC
    Cancer Epidemiol Biomarkers Prev; 1992; 1(7):555-9. PubMed ID: 1302568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities.
    Harrelson JP; Lee MW
    Pharmacol Ther; 2016 Nov; 167():60-73. PubMed ID: 27498404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug discovery for breast cancer and co-instantaneous cardiovascular disease: what is the future?
    Yin L; Hu Q
    Future Med Chem; 2013 Mar; 5(4):359-62. PubMed ID: 23495679
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer. Cholesterol and cancer, in the balance.
    Silvente-Poirot S; Poirot M
    Science; 2014 Mar; 343(6178):1445-6. PubMed ID: 24675946
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal.
    Soucek P; Vrana D; Ueng YF; Wei S; Kozevnikovova R; Guengerich FP
    Clin Chem Lab Med; 2018 Feb; 56(3):e78-e81. PubMed ID: 28915107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer culprit? A common product of cholesterol may fuel breast tumor growth.
    Moyer MW
    Sci Am; 2014 Apr; 310(4):18. PubMed ID: 24712111
    [No Abstract]   [Full Text] [Related]  

  • 37. The Role of Cholesterol in Cancer.
    Kuzu OF; Noory MA; Robertson GP
    Cancer Res; 2016 Apr; 76(8):2063-70. PubMed ID: 27197250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer: novel therapeutic targets.
    Yip GW
    Recent Pat Anticancer Drug Discov; 2011 May; 6(2):164-5. PubMed ID: 21449881
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholesterol metabolism and breast cancer.
    Stadler SC; Hacker U; Burkhardt R
    Curr Opin Lipidol; 2016 Apr; 27(2):200-1. PubMed ID: 26959708
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in breast cancer diagnosis and treatment. Two new studies reveal novel treatments, another explores cell movement's impact on cancer proliferation, and another make a case for smaller, faster clinical trials.
    Duke Med Health News; 2011 Dec; 17(12):1-2. PubMed ID: 27024318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.